WWW.LEXPERT.CA
|
2019
|
LEXPERT 17
Jodoin, Claude E. Fasken Martineau DuMoulin LLP
(514) 397-7489 cjodoin@fasken.com
Mr. Jodoin practises tax law, with a focus on corporate financing, financial
instruments, the purchase and sale of companies, and reorganizations.
He regularly assists financial institutions during major mandates dealing
with large public issues of securities. He also advises large national
and international public and private corporations on reorganization.
Jenkins, William K. Dentons Canada LLP
(403) 268-6835 bill.jenkins@dentons.com
Mr. Jenkins has a diverse transaction-based practice advising on the
structuring and implementation of debt and equity financings, project
financings, mergers & acquisitions and joint ventures. He was the presiding
member of the National Partnership Board of Dentons Canada from 2009 to
2015 and participated in the formation of Dentons, serving as the first Global
Vice Chair of Dentons from Canada.
Jackson, Kibben Fasken Martineau DuMoulin LLP
(604) 631-4786 kjackson@fasken.com
Mr. Jackson is a corporate/commercial litigator in the Vancouver office who
specializes in insolvency. He is sought after for his experience in corporate
restructurings, secured creditor realization and acting for court's officers in
all manner of insolvency processes. Clients appreciate his ability to guide
them in the face of evolving insolvency legislation and judicial developments.
Hurst, Michael A. Dentons Canada LLP
(403) 268-3046 michael.hurst@dentons.com
Mr. Hurst's energy law expertise embraces oil & gas upstream, midstream
and pipeline acquisitions; structuring greenfield projects; financing; and
product sales arrangements. He works on infrastructure projects in Canada
and South America. He has worked on infrastructure projects in the Western
Canada Sedimentary Basin, the Canadian Arctic and offshore areas and
South America.
Huot, Jean Marc Stikeman Elliott LLP
(514) 397-3276 jmhuot@stikeman.com
Mr. Huot is a partner in the Corporate Group. His practice is focused
primarily in the areas of securities and mergers & acquisitions.
Hueppelsheuser, Darren D.
Norton Rose Fulbright Canada LLP
(403) 267-8242 darren.hueppelsheuser@nortonrosefulbright.com
Mr. Hueppelsheuser's practice concentrates on income tax law,
with an emphasis on the tax aspects of financing and transaction
planning for corporations and partnerships in both private and public
transactions. He also advises with respect to international tax structuring
of Canadian inbound and outbound investments. He regularly makes
presentations on cross-border and domestic tax issues.
LEXPERT-RANKED LAWYERS
(Competition) and Sean Boyle (Litigation).
But there were other transactions that made the
news in the cannabis space. Particularly those done
by Aurora Cannabis, one of the world's largest and
leading cannabis companies with sales and opera-
tions in 14 countries across five continents.
On May 2, 2018, Aurora Cannabis completed
its $1.23 billion (US$950 million) take-over bid
for all of the outstanding shares of CanniMed
erapeutics Inc. In addition to product syner-
gies and broader product portfolio, the combina-
tion also provides for expanded geographies. e
CanniMed Shares were acquired for consideration
of approximately 72.7 million Aurora shares and
$140 million in cash. e CanniMed Shares were
de-listed from the Toronto Stock Exchange at the
close of business on May 1, 2018.
McMillan LLP acted as counsel to Aurora
Cannabis with a team led by Desmond Balakrish-
nan and comprising Cory Kent, Leo Raffin, Paul
Davis, Ravipal Bains, Leila Rafi and Kosta Kostic
(Capital Markets and M&A), Herb Ono (US
Securities), Geoff Moysa, Brett Harrison and
Charlotte Conlin (Litigation), Peter Botz (Tax),
François Tougas and Ryan Gallagher (competi-
tion), with assistance from Dorsey & Whitney
LLP (US Tax and Securities).
Borden Ladner Gervais LLP acted as counsel
to CanniMed erapeutics with a team led by
Philippe Tardif and comprising Jason Saltzman,
Andrew Powers, Mark Wheeler, Colin Cameron-
Vendrig, Pierre Permingeat, Joseph Di Ponio,
Rocky Swanson (Capital Markets and M&A),
Denes Rothschild (Competition), Danny Lang
(Tax), Jim Douglas, Cait Sainsbury, Graham
Splawski and Ashley omassen (Litigation), with
assistance from Dickinson Wright LLP (US Cor-
porate and Securities).
Stikeman Elliott LLP acted a counsel to the spe-
cial committee of the board of directors of Can-
niMed erapeutics with a team led by Donald
Belovich and comprising Simon Romano, Mihkel
Voore, Ryan Kirvan, Logan Copen, David Tar-
dif, Victor MacDiarmid, Spencer Burger, Peter
Buckles (M&A and Securities), Peter Howard,
Samaneh Hosseini, Sinziana Hennig, Zev Smith
(Litigation), Michael Kilby (Competition) and
Dean Kraus (Tax).
Not much later, on July 25, 2018, Aurora Can-
nabis Inc. completed the acquisition of MedRe-
leaf Corp. in a transaction valued at US$2.5 bil-
lion. e transaction was supported by certain
key shareholders of MedReleaf and announced
in May 2018. e friendly all-stock acquisition
was finalized pursuant to a court ordered plan
of arrangement in the Ontario Supreme Court
of Justice.
e new entity has more than 1,200 employees
and is designed to become the largest Canadian
